FDA’s Blue Print for Innovation
The Food and Drug Administration (FDA) is one of the most important federal agencies in America. The agency regulates…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
FDA REMS: Blue Print for Prescriber Continuing Education Program for…
The Food and Drug Administration (FDA) released a “Blueprint for Prescriber Continuing Education Program” regarding the use of…
NY Times: Medical Experts on Guidelines Panels – Not Welcome?
Last week, the New York Times joined a long list of other media sources who have begun using ad hominem attacks on clinical…
Government Targeting Pharmaceutical Executives with Renewed Enthusiasm
Over the past several years, we have seen an increasing focusing on litigation and prosecution of large pharmaceutical and medical…
AHRQ National Resource Center for Academic Detailing
The rate at which medicine, science and technology advance our current health care system is rapid. Each day, more and more…
Open Education Trends Transform the Future of Professional Medical…
Pri-Med, a brand owned and operated by M|C Communications and a leading provider of professional education solutions to a…
Physician Payment Sunshine Act: CMS Credits Delay on Reducing Regulatory…
Exactly two weeks after Senators Herb Kohl (D-WI) and Charles Grassley (R-IA), co-sponsors of the Physician Payment Sunshine Act…
Healthcare Fraud Prosecution Significantly Increased in First Half of 2011
According to a recent clearinghouse report, federal criminal prosecutions of health care fraud are up—way up—this year. According…
Patient Groups Encourage Congress to Remove Burdensome FDA Rules
Patient organizations are encouraging congress to drop burdensome conflict of interest quotas on FDA advisory panels which are…
ACCME October News: Reminding Providers to Enter 2011 Activity Data
In this month’s Accreditation Council for Continuing Medical Education (ACCME) newsletter, the ACCME reminded providers of several…